{"id":2987,"date":"2017-12-01T07:30:00","date_gmt":"2017-12-01T07:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/forsta-xps-installerad-i-kina\/"},"modified":"2017-12-01T07:30:00","modified_gmt":"2017-12-01T07:30:00","slug":"forsta-xps-installerad-i-kina","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/","title":{"rendered":"F\u00f6rsta XPS\u2122 installerad i Kina"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>XVIVO Perfusion har installerat den f\u00f6rsta XPS\u2122 i Kina. Syftet \u00e4r att starta en EVLP (Ex Vivo Lung Perfusion) -studie p\u00e5 Shanghai Pulmonary Hospital. Studien \u00e4r utformad f\u00f6r att komplettera befintliga EVLP-data med kinesisk data. F\u00f6retaget planerar att inleda en godk\u00e4nnandeprocess f\u00f6r XPS\u2122 hos CFDA (China Food and Drug Administration). STEEN Solution\u2122 och Perfadex \u00e4r redan godk\u00e4nda av CDFA.<\/strong><\/div>\n<p><span>Kina \u00e4r f\u00f6r n\u00e4rvarande v\u00e4rldens snabbast v\u00e4xande lungtransplantationsmarknad med en \u00f6kning om 37% i antal lungtransplantationer 2016 (201 genomf\u00f6rda lungtransplantationer). P\u00e5 grund av det \u00f6kade behovet av lungtransplantation har antalet kliniker som \u00e4r godk\u00e4nda f\u00f6r att genomf\u00f6ra lungtransplantationer \u00f6kat fr\u00e5n 20 kliniker 2016 till 27 kliniker 2017. Samtidigt med tillv\u00e4xten av transplantationscentra v\u00e4xer organdonationssystemet i Kina f\u00f6r att m\u00f6ta efterfr\u00e5gan p\u00e5 denna livr\u00e4ddande behandling. Det nuvarande organdonationssystemet \u00e4r ett OPO-system, med f\u00f6rv\u00e4ntan att dra nytta av \u00f6kad anv\u00e4ndning av marginella EVLP lungor f\u00f6r transplantation. M\u00e5let f\u00f6r detta samarbete \u00e4r att minska d\u00f6dligheten p\u00e5 v\u00e4ntelistan.<\/span><\/p>\n<p><span>Lungtransplantationsprogrammet som leds av professor Jiang Gening kommer att utf\u00f6ra den f\u00f6rsta EVLP-studien i Kina f\u00f6r att unders\u00f6ka effekterna av EVLP p\u00e5 lungtransplantation. Unders\u00f6kningen \u00e4r en sjukhusinitierad singelcenter studie med avsikt att addera kinesiska data till befintliga EVLP-data fr\u00e5n Nordamerika och Europa. F\u00f6retaget planerar att initiera en registreringsprocess f\u00f6r XPS\u2122 hos CFDA. I samarbete med XVIVO Perfusions distribut\u00f6r i Kina (Genext Ltd) planeras att vetenskapligt st\u00f6dja Lungtransplantationskliniken vid Shanghai Pulmonary Hospital, det ledande sjukhuset f\u00f6r behandling av lungsjukdomar i Kina. Sjukhuset har \u00f6ver 1000 sjukhusplatser och utf\u00f6rde mer \u00e4n 10 000 thorax-kirurgiska operationer f\u00f6rra \u00e5ret. Med tillg\u00e5ng till XPS\u2122-systemet har Shanghai Pulmonary Hospital som m\u00e5l att bli \u2019Center of Excellence\u2019 f\u00f6r EVLP i Asien.<\/span><\/p>\n<p><span>&#34;Det \u00e4r gl\u00e4djande att den f\u00f6rsta XPS\u2122 i Kina installerats med avsikt att g\u00f6ra en klinisk studie. Kina har lagt mycket arbete p\u00e5 att \u00f6ka antalet transplantationer och det har, om \u00e4n fr\u00e5n en l\u00e5g niv\u00e5, resulterat i snabb tillv\u00e4xt de senaste tre \u00e5ren. Med tanke p\u00e5 befolkningens storlek, samt den snabba \u00f6kningen av levnadsstandard och standard inom h\u00e4lso- och sjukv\u00e5rd, f\u00f6rv\u00e4ntas Kina bli en viktig marknad f\u00f6r XVIVO i en inte alltf\u00f6r avl\u00e4gsen framtid, s\u00e4ger Magnus Nilsson, VD f\u00f6r XVIVO Perfusion.<\/span><\/p>\n<p><span>G\u00f6teborg den 1 december 2017<br \/> Magnus Nilsson, VD<br \/><\/span>XVIVO Perfusion AB (publ)<\/p>\n<div class=\"mfn-footer\">\n<p><span>F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com<br \/>Magnus Nilsson, VD, +46 31-788 21 50, magnus.nilsson@xvivoperfusion.com<\/span><\/p>\n<p><span>F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/span><\/p>\n<p><span>Denna information \u00e4r s\u00e5dan information som Xvivo Perfusion AB (publ) \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande klockan 8:30 den 1 december 2017.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>XVIVO Perfusion har installerat den f\u00f6rsta XPS\u2122 i Kina. Syftet \u00e4r att starta en EVLP (Ex Vivo Lung Perfusion) -studie&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2987","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>F\u00f6rsta XPS\u2122 installerad i Kina - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00f6rsta XPS\u2122 installerad i Kina - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion har installerat den f\u00f6rsta XPS\u2122 i Kina. Syftet \u00e4r att starta en EVLP (Ex Vivo Lung Perfusion) -studie...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forsta-xps-installerad-i-kina\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forsta-xps-installerad-i-kina\\\/\",\"name\":\"F\u00f6rsta XPS\u2122 installerad i Kina - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2017-12-01T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forsta-xps-installerad-i-kina\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forsta-xps-installerad-i-kina\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forsta-xps-installerad-i-kina\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00f6rsta XPS\u2122 installerad i Kina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00f6rsta XPS\u2122 installerad i Kina - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/","og_locale":"en_US","og_type":"article","og_title":"F\u00f6rsta XPS\u2122 installerad i Kina - XVIVO","og_description":"XVIVO Perfusion har installerat den f\u00f6rsta XPS\u2122 i Kina. Syftet \u00e4r att starta en EVLP (Ex Vivo Lung Perfusion) -studie...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/","name":"F\u00f6rsta XPS\u2122 installerad i Kina - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2017-12-01T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forsta-xps-installerad-i-kina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"F\u00f6rsta XPS\u2122 installerad i Kina"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}